Invitation
Welcome to the 3rd Annual Skin Basics for Primary Care Conference
We are pleased to invite Primary Care Practitioners to join us for the 3rd Annual Skin Basics for Primary Care (SBPC) Conference, taking place in September 2026 at the Toronto Marriott Markham. This full-day program is designed specifically to support primary care clinicians looking to strengthen their dermatology knowledge and confidence.
Our faculty of expert dermatologists will cover essential fundamentals, practical approaches, and updates on new and emerging treatments relevant to everyday practice. Join us for an engaging day of learning, discussion, and skill-building as we explore the core elements of dermatologic care together.
We look forward to welcoming you and supporting your continued excellence in patient care.
Your Co-Chairs,
Dr. Patrick Fleming, BSc(Nutrition), MSc(Community Health), MD, FRCPC
Dermatologist & Investigator, York Dermatology & Research Centre
Dr. Kyle O. Lee, BMLSc, BMBS, MPH, CCFP
Assistant Professor, Department of Family & Community Medicine, University of Toronto
Who Should Attend
- General practitioners
- Family physicians
- Pediatricians
- Nurse practitioners
- Physician assistants
- Pharmacists
- Medical trainees
September 19, 2026
Toronto Marriott Markham Markham, ON
The 3rd Annual SBPC Conference will take place at the Toronto Marriott Markham, a modern, upscale hotel located in the heart of Downtown Markham. The hotel’s contemporary meeting facilities provide an ideal setting for the SBPC, offering a comfortable and professional environment for learning and collaboration. Free parking is available to delegates driving in for the day.
Guests who wish to stay onsite may book accommodations directly with the hotel. A dedicated hotel booking link is provided for your convenience.
Address: 170 Enterprise Boulevard Markham, Ontario
For a copy of the 2025 or 2024 Final Program, please contact the Conference Secretariat.
Program
Saturday, September 19, 2026
Continuing Professional Development: this conference is an unaccredited activity.
| 8:30am–9:30am | Registration Opens & Continental Breakfast |
| 9:30am–9:40am | Welcome and Introduction Dr. Patrick Fleming / Dr. Kyle Lee |
| 9:40am–10:25am |
Individualized Medicine for Pediatrics: Advanced Targeted Topical Learning objectives of the session: 1. Examine the role of patch testing and the impact food allergies play in managing pediatric atopic dermatitis
|
| 10:30am–11:00am |
Modern Isotretinoin: The Lidose Difference And Why It Matters
|
| 11:05am–11:35am | Hand Eczema Speaker: TBC Sponsored by LEO Pharma |
| 11:40am–12:10pm |
TITLE TBC Learning Objectives:Sponsored by L’Oreal Dermatological Beauty |
| 12:10pm–1:00pm |
Lunch Break (included) |
| 1:00pm–1:45pm |
Practical Approaches to the Management of Acne & Onychomycosis in Primary Care Learning Objectives:1. Describe the clinical features of each dermatologic condition
|
| 1:50pm–2:20pm |
Innovation in Psoriasis Care: Learn about the management of plaque psoriasis using novel non-steroidal topical treatments Learning Objectives:
1. Identify which plaque psoriasis patients are most appropriate for emerging non-steroidal topical treatments based on efficacy, safety, and tolerability profiles.
|
| 2:20pm–2:45pm |
Coffee Break |
| 2:45pm–3:15pm |
Chronic Spontaneous Urticaria: Prevalence, Impact, and Unmet Clinical Needs Learning Objectives:
|
| 3:20pm–3:50pm |
Advances in Therapeutic Moisturizers: Best Practices for the Treatment of Atopic Dermatitis Sponsored by Beiersdorf / Eucerin |
| 3:55pm-4:25pm |
Plenary Presentation Learning Objectives:
|
| 4:25pm-4:30pm | Closing Comments Dr. Patrick Fleming / Dr. Kyle Lee |
2026 Presenters
Erin Dahlke
Skin Cancer in Primary Care – An approach to keratinocyte carcinomas
3:55pm – 4:25pm
Dr. Dahlke is the Division Head for Dermatology at St. Joseph’s Health Centre and leads the Mohs micrographic surgery unit. She is an adjunct Assistant Professor at both the University of Toronto and Queens University and is actively engaged in medical education. Her research interests include skin cancer treatment, equity and diversity in medical education, and quality improvement initiatives focused on patient experience. Clinically Dr. Dahlke specializes in Mohs Micrographic Surgery, with a focus on providing excellent functional and aesthetic outcomes in post-tumour extirpation facial reconstruction.
Patrick Fleming, MD, FRCPC
Innovation in Psoriasis Care – Novel Non-Steroidal Topical Therapy
1:50pm – 2:20pm
Dr. Patrick Fleming is a dermatologist with focus on inflammatory skin disease including psoriasis, atopic dermatitis, & prurigo nodularis. He is an Assistant Professor of Medicine at the University of Toronto. He completed residency at the University of Toronto where he was Chief Dermatology Resident and concurrently completed the Global Clinical Scholars program in Clinical Trials at Harvard Medical School. He also holds a Master’s degree in Community Health, a Graduate Certificate in Medical Education, and was the Gold Medalist in medical school. He is an Associate Editor the Journal of Cutaneous Medicine and Surgery. Dr. Fleming’s research background includes systematic reviews and he is an investigator for dermatology clinical trials.
Kyle Lee, BMLSc, BMBS, MPH, CCFP
Session Moderator
Dr. Kyle O. Lee is an Academic Family Physician and Assistant Professor at the University of Toronto with over 10 years of clinical experience, currently practicing at Sumac Creek Health Centre within the St. Michael’s Academic Family Health Team. He holds a Master of Public Health from the Dalla Lana School of Public Health (University of Toronto), a Bachelor of Medicine and Surgery from the University of Limerick, and completed his family medicine residency at St. Michael’s Hospital, University of Toronto.
With a particular passion for dermatology education, Dr. Lee serves as Co-Chair of the Scientific Committee for Skin Basics for Primary Care, a full-day CME conference dedicated to upskilling clinicians in dermatology, and has contributed to peer-reviewed publications on atopic dermatitis and psoriasis management for primary care providers. He has consulted and spoken at numerous national and international educational events and advisory boards, partnering with organizations including the Eczema Society of Canada, International Centre for Professional Development in Health and Medicine, Centre for Effective Practice, CPD Network and many others, and brings a clinician-centred, evidence-based perspective to primary care dermatology education.
Daniel Li, MD, FRCPC
Individualized Medicine for Pediatrics: Advanced Targeted Topical Treatments in Management of Atopic Dermatitis
9:40am – 10:25am
Dr. Daniel Li is a Clinical Immunologist and Allergist with a special interest in inflammatory skin conditions. He received his medical degree from the University of Toronto before completing residency training in Internal Medicine and two years of fellowship training in Allergy and Clinical Immunology at the University of Toronto.
He practices in Stoney Creek and Niagara Falls, Ontario. Dr. Li is actively involved in clinical research and serves as an investigator with Probity Medical Research Inc. He has contributed to over 18 clinical trials in atopic dermatitis and chronic spontaneous urticaria through his work with Allergy Research Canada Inc and LEADER Research.
He also holds an appointment as Adjunct Assistant Clinical Professor at McMaster University, where he is involved in clinical teaching
Carrie Lynde
Modern Isotretinoin: The Lidose Difference And Why It Matters
10:30am – 11:00am
Dr. Carrie Lynde is a board-certified dermatologist who practises at Lynde Institute for Dermatology in Markham. She is a member of the Canadian Dermatology Association.
Dr. Lynde completed her HBSc (0T2), LLB (UWO 2005), Medical Degree (0T9) and Residency in Dermatology at the University of Toronto in 2014. Dr Lynde completed a fellowship in Laser and Esthetic Medicine at the University of Toronto in 2015.
Dr. Lynde acts as an investigator for clinical trials including those for novel skin therapeutics at Lynderm Research and Probity Research. She has published papers in peer-reviewed journals and has spoken at national dermatology scientific conferences.
Practical Approaches to the Management of Acne & Onychomycosis in Primary Care
1:00 – 1:45pm
Adam Natsheh is a board-certified dermatologist and a member of the division of Dermatology with the University of Toronto. He practices at Women’s College Hospital and at a group dermatology practice in North York. He regularly gives presentations to health care professionals helping to simplify dermatology therapeutics and giving attendees the necessary tools to be successful with their patient interactions.
Cathryn Sibbald, MD, MSc, FRCPC, DABD
Individualized Medicine for Pediatrics: Advanced Targeted Topical Treatments in Management of Atopic Dermatitis
9:40am – 10:25am
Dr. Cathryn Sibbald is an Associate Professor at the University of Toronto and a full-time staff physician in the Division of Dermatology at the Hospital for Sick Children. She also works at St Joes hospital in Toronto. She completed her dermatology residency training at the University of Toronto followed by fellowship training in Pediatric Dermatology at the Children’s Hospital of Philadelphia. She has interests in autoimmune and inflammatory skin conditions and impacts on quality of life, and co-leads alopecia, morphea and Hidradenitis specialty clinics at SickKids, an adult morphea clinic at Mount Sinai, and a transition clinic at St Joes.
Daniel Wong, MD, FRCPC
Individualized Medicine for Pediatrics: Advanced Targeted Topical Treatments in Management of Atopic Dermatitis
9:40am – 10:25am
Dr. Daniel Wong is a board-certified dermatologist. He earned a Bachelor’s degree in Medical Sciences studying Clinical Biochemistry at Western University. Dr. Wong then went on to obtain his Medical Doctorate from Western University. He completed his 5-year dermatology residency at the University of Toronto and is currently an Assistant Clinical Professor in the Department of Medicine at McMaster University. Dr. Wong is co-founder of Benchmark Dermatology in Burlington, and also works as an associate at Refine Dermatology in Oakville. His interests include skin cancer, inflammatory skin conditions, pruritus, and medical education.
Registration
Registration is now open!
All fees are in Canadian dollars and subject to taxes of 13% HST. Registration includes continental breakfast, lunch and parking.
| REGULAR – to Sept 12 |
LATE – Sept 12 – 19 |
|
| Primary Care Practitioner | $90.00 | $130.00 |
| Industry Sponsor* | $265.00 | $370.00 |
*Sponsoring companies may purchase up to 2 additional registrations for representatives.
All registration fees will be refunded less a $20.00 + applicable taxes for refund requests received on or prior to August 21, 2026. No refunds will be available for cancellations received on or after August 22, 2026. All requests must be received in writing. No telephone cancellations will be accepted. Submit cancellation letters to the Conference Secretariat at the email noted above.
Questions?
If you have any questions, please contact the Conference Secretariat by email at [email protected] or by phone at (604) 738-8600.
Sponsors
.
2026 DIAMOND SPONSORS
With the belief that patients deserve better than the current standard of care, the Arcutis team brings a sense of urgency, simplifying disease management and optimizing drug efficacy, safety, and tolerability to meet the needs of healthcare providers and patients. Arcutis has the potential to advance the standard of care for plaque psoriasis, atopic dermatitis, seborrheic dermatitis, and scalp psoriasis.
Bausch Health, Canada Inc., headquartered in Laval, Quebec, is part of Bausch Health Companies Inc. (NYSE/TSX: BHC), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes. Bausch Health, Canada Inc. is a leader in the medical dermatology market in Canada and provides treatments for chronic weight management, allergy, neuroscience, and cardio-metabolic conditions. Our two manufacturing facilities in Canada are for prescription pharmaceuticals, including many of our leading dermatological products. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees, and investors.
Learn more at www.bauschhealth.ca. Information for Canadian health professionals is available at www.bauschhealthresources.ca.
2026 GOLD SPONSORS
Beiersdorf Canada is one of more than 150 international affiliates of the cosmetics company Beiersdorf AG which is based in Hamburg, Germany. For over 130 years, we have dedicated ourselves to meeting our consumers’ individual needs and are considered to be the inventors of modern skin care. Our international success is founded on our research and development expertise, our innovative products, and our strong brands. Beiersdorf’s NIVEA is the world’s No.1 skin care brand*. Other names in its successful international brand portfolio include Eucerin, La Prairie, Labello, 8×4, and Hansaplast. Subsidiary tesa SE is one of the world’s leading producers of self-adhesive products and system solutions for industry, craft businesses, and consumers.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the U.S., and South America.
Our brands CeraVe, La Roche-Posay, SkinBetter, SkinCeuticals and Vichy, offer a broad range of options to address the health and beauty of everyone, everywhere.
LEO Pharma is a global leader in medical dermatology. We deliver innovative solutions for skin health, building on a century of experience with breakthrough medicines in healthcare. We are committed to making a fundamental difference in people’s lives, and our broad portfolio of treatments serves close to 100 million patients in over 70 countries annually. Headquartered in Denmark, LEO Pharma has a team of 4,000 people worldwide. LEO Pharma is co-owned by majority shareholder the LEO Foundation and, since 2021, Nordic Capital. For more information, visit www.leo-pharma.com.
2026 SILVER SPONSORS
As part of the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good every day. In partnership with skin experts and dermatologists, we create innovative products that include treatments for acne and eczema, gentle skin-loving cleansers, moisturizers that repair the skin barrier and sunscreens that defend against inflammation, premature aging, and skin cancer.
